FIELD: experimental medicine.
SUBSTANCE: the present innovation deals with modeling urinary calculosis in rats due to injecting intraperitoneally 60%-glucose solution at 1 ml/100 g animal body weight twice daily for 2 mo. The method is very simple and enables to achieve lithogenesis in 25% experimental animals.
EFFECT: higher efficiency of experimental modeling.
2 dwg, 2 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR FORMING AN EXPERIMENTAL MODEL OF A COMBINATION OF TYPE 1 DIABETES MELLITUS AND ENDOMETRIOSIS | 2021 |
|
RU2776727C1 |
| METHOD FOR PREVENTING AND TREATING THE CASES OF UROLITHIASIS | 2005 |
|
RU2271837C1 |
| METHOD FOR MODELING OSTEOPOROSIS WITH STREPTOZOTOCIN-INDUCED DIABETES MELLITUS IN RATS | 2019 |
|
RU2712153C1 |
| METHOD OF DIAGNOSING DEVELOPMENT OF INFLAMMATION DURING BACKGROUND OF METABOLIC SYNDROME IN EXPERIMENT | 2022 |
|
RU2813621C2 |
| METHOD FOR PREVENTION AND TREATMENT OF CARBOHYDRATE AND LIPID METABOLISM DISORDER IN METABOLIC SYNDROME AND ENCEPHALOPATHY, USE OF TETRAPEPTIDE AND PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF SUCH DISORDERS | 2012 |
|
RU2480234C1 |
| MEDICATION FOR PREVENTION AND CORRECTION OF DIABETES MANIFESTATIONS | 2012 |
|
RU2563234C2 |
| METHOD OF PREVENTING POST-RESECTION HYPERGLYCAEMIA IN EXPERIMENT | 2007 |
|
RU2354393C1 |
| METHOD OF CORRECTING METABOLIC SYNDROME UNDER EXPERIMENTAL CONDITION | 2022 |
|
RU2806875C1 |
| METHOD FOR PRODUCING RABBIT PANCREATIC BETA CELLS AND COMPOSITION FOR STIMULATING NATURAL INSULIN DEVELOPMENT IN PATIENT | 2007 |
|
RU2450052C2 |
| AGENT FOR METABOLIC SYNDROME CORRECTION | 2011 |
|
RU2458935C1 |
